Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells

Journal of Leukocyte Biology

Volumn 84, Issue 3, 2008, Pages 644-650

  Varga, Georg ^a   Ehrchen, Jan ^a   Tsianakas, Athanasios ^a   Tenbrock, Klaus ^a   Rattenholl, Anke ^a   Seeliger, Stephan ^a   Mack, Matthias ^b   Roth, Johannes ^a   Sunderkoetter, Cord ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

CD124; IL 10

Indexed keywords

CD11B ANTIGEN; CD163 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; GLUCOCORTICOID; INTERLEUKIN 10; INTERLEUKIN 4 RECEPTOR ALPHA; L SELECTIN;

ADHESION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DOWN REGULATION; EXPERIMENTAL MOUSE; IMMUNOSUPPRESSIVE TREATMENT; MELANOMA B16; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD; ANTIGENS, CD11B; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; DEXAMETHASONE; HUMANS; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; MACROPHAGES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; MYELOID CELLS; PHENOTYPE; RECEPTORS, CELL SURFACE; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

MURINAE; MUS;

EID: 50849139609     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1107768     Document Type: Article

References (23)

1. Amsterdam, A., Tajima, K., Sasson, R. (2002) Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem. Pharmacol. 64, 843-850.
2. Ehrchen, J., Steinmuller, L., Barczyk, K., Tenbrock, K., Nacken, W., Eisenacher, M., Nordhues, U., Sorg, C., Sunderkotter, C., Roth, J. (2007) Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 109, 1265-1274.
3. Mosser, D. M. (2003) The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212.
4. Gordon, S., Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
5. Wells, C. A., Ravasi, T., Hume, D. A. (2005) Inflammation suppressor genes: please switch out all the lights. J. Leukoc. Biol. 78, 9-13.
6. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
7. Grage-Griebenow, E., Flad, H. D., Ernst, M. (2001) Heterogeneity of human peripheral blood monocyte subsets. J. Leukoc. Biol. 69, 11-20.
8. Grage-Griebenow, E., Zawatzky, R., Kahlert, H., Brade, L., Flad, H., Ernst, M. (2001) Identification of a novel dendritic cell-like subset of CD64(+)/CD16(+) blood monocytes. Eur. J. Immunol. 31, 48-56.
9. Sunderkotter, C., Nikolic, T., Dillon, M. J., Van, R. N., Stehling, M., Drevets, D. A., Leenen, P. J. (2004) Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 172, 4410-4417.
10. Geissmann, F., Jung, S., Littman, D. R. (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82.
11. Biermann, H., Pietz, B., Dreier, R., Schmid, K. W., Sorg, C., Sunderkotter, C. (1999) Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors. J. Leukoc. Biol. 65, 217-231.
12. Strauss-Ayali, D., Conrad, S. M., Mosser, D. M. (2007) Monocyte subpopulations and their differentiation patterns during infection. J. Leukoc. Biol. 82, 244-252.
13. Sica, A., Bronte, V. (2007) Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117, 1155-1166.
14. Mack, M., Cihak, J., Simonis, C., Luckow, B., Proudfoot, A. E., Plachy, J., Brühl, H., Frink, M., Anders, H., Vielhauer, V., Pfirstinger, J., Stangassinger, M., Schlöndorff, D. (2001) Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166, 4697-4704.
15. Vidal-Vanaclocha, F., Amezaga, C., Asumendi, A., Kaplanski, G., Dinarello, C. A. (1994) Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res. 54, 2667-2672.
16. Viemann, D., Strey, A., Janning, A., Jurk, K., Klimmek, K., Vogl, T., Hirono, K., Ichida, F., Foell, D., Kehrel, B., Gerke, V., Sorg, C., Roth, J. (2005) Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 105, 2955-2962.
17. Varga, G., Balkow, S., Wild, M. K., Stadtbaeumer, A., Krummen, M., Rothoeft, T., Higuchi, T., Beissert, S., Wethmar, K., Scharffetter-Kochanek, K., Vestweber, D., Grabbe, S. (2007) Active MAC-1 (CD11b/CD18) on DCs inhibits full T-cell activation. Blood 109, 661-669.
18. Krummen, M. B., Varga, G., Steinert, M., Stuetz, A., Luger, T. A., Grabbe, S. (2006) Effect of pimecrolimus vs. corticosteroids on murine bone marrow-derived dendritic cell differentiation, maturation, and function. Exp. Dermatol. 15, 43-50.
19. Gallina, G., Dolcetti, L., Serafini, P., De, S. C., Marigo, I., Colombo, M. P., Basso, G., Brombacher, F., Borrello, I., Zanovello, P., Bicciato, S., Bronte, V. (2006) Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J. Clin. Invest. 116, 2777-2790.
20. Mozo, L., Suarez, A., Gutierrez, C. (2004) Glucocorticoids up-regulate constitutive interleukin-10 production by human monocytes. Clin. Exp. Allergy 34, 406-412.
21. Williams, L., Jarai, G., Smith, A., Finan, P. (2002) IL-10 expression profiling in human monocytes. J. Leukoc. Biol. 72, 800-809.
22. Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., Achong, M. K. (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101, 311-320.
23. Karagas, M. R., Cushing Jr., G. L., Greenberg, E. R., Mott, L. A., Spencer, S. K., Nierenberg, D. W. (2001) Non-melanoma skin cancers and glucocorticoid therapy. Br. J. Cancer 85, 683-686.